
Sanstar Ltd Files IPO Proposal with SEBI for Plant-Based Products Expansion.image/iStock
Sanstar Ltd Files IPO Proposal with SEBI for Plant-Based Products Expansion
Sanstar Ltd has submitted its draft red herring prospectus (DRHP) to the Securities and Exchange Board of India (SEBI) in anticipation of an upcoming initial public offering (IPO). This Ahmedabad-based enterprise specializes in producing plant-based specialty products and ingredient solutions utilized across various industrial, animal nutrition, and food applications within India.
In this exciting development, Sanstar Limited’s IPO encompasses an offer for sale (OFS) by selling shareholders, involving up to 8 million shares, and a fresh issue of up to 40 million shares. The company may also consider a pre-IPO placement of up to 4 million shares, contingent upon discussions with the Book Running Lead Manager (BRLM). The face value of a company share is ₹2.
The proposed utilization of fresh issue proceeds includes funding part of the capital expenditure required for expanding the Dhule facility, amounting to approximately ₹182 crores. Additionally, the remaining net proceeds, up to ₹100 crores, are earmarked for specific borrowing repayment and/or prepayment. Any net proceeds beyond expenses will be directed towards general corporate needs and issue costs.
In the fiscal year 2023, the company reported consolidated revenue of approximately ₹1,180 crores, with an EBITDA of about ₹73 crores and a Profit After Tax (PAT) of roughly ₹42 crores. The company’s Return on Equity (ROE) and Return on Capital Employed (ROCE) stood at approximately 28% and 24%, respectively. On a stand-alone basis, revenue, EBITDA, and PAT demonstrated a Compound Annual Growth Rate (CAGR) of around 57%, 39%, and 71%, respectively, between FY21 and FY23.
Sanstar boasts a global presence, exporting its products to over 45 nations across the Middle East, Africa, Asia, Americas, Europe, and Oceania. Notably, more than 30% of the company’s total revenue is derived from exports. The company’s Kutch facility holds registration with the US Food and Drug Administration (USFDA), underlining its commitment to quality standards.
Sanstar Ltd Files IPO Proposal with SEBI for Plant-Based Products Expansion:In case of rectification of any error in article , Visit on Correction Policy & Register your Query:
Latest Posts
- Meta, Google Tell Delhi High Court They Cannot Proactively Remove Unauthorised Court Videos
July 7, 2026 | Breaking News, India - Maharashtra Rains: Death Toll Rises as IMD Issues Alerts, Mumbai Faces Severe Disruptions
July 7, 2026 | Breaking News, India, Weather - Gujarat Court Upholds Death Sentence For 38 convicts In 2008 Ahmedabad Blasts Case
July 7, 2026 | Breaking News, India - Jammu Kashmir: Entire Staff of Ramban School Suspended After Student Found Locked Inside Building
July 7, 2026 | Breaking News, Jammu Kashmir, Ramban - Oil Tanker Hit by ‘Unknown Projectile’ Near Strait of Hormuz, Fire Breaks Out
July 7, 2026 | Breaking News, Politics, World - Netanyahu Urges US Not to Sell F-35 Fighter Jets to Turkey Over Regional Power Balance
July 7, 2026 | Breaking News, Politics, World - Flash Flood, Cloudburst Cause Widespread Damage in Jammu Kashmir’s Thathri Doda
July 7, 2026 | Breaking News, Doda, Jammu Kashmir - 23 Killed, Over 100 Injured in Sri Lanka’s Deadliest Prison Riot in Years
July 7, 2026 | Breaking News, World - Microsoft to Cut ~4,800 Jobs to Accelerate AI Investment
July 7, 2026 | Breaking News, Business, World - Senior Congress leader Meenakshi Natarajan to move Madhya Pradesh High Court challenging her RS nomination rejection
July 6, 2026 | Breaking News, India, Politics